Moreover, the circRNA-SFMBT2/RNF181 axis strengthened ERα stability by differentially modulating K-63-linked and K48-linked ERα ubiquitination, leading to overexpression of ERα target genes as well as BC progression [95]. The gene discussed is ESR1; the disease is breast cancer.